The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global β-Nicotinamide Mononucleotide Market Research Report 2024
Synopsis
Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide.
The global β-Nicotinamide Mononucleotide market was valued at US$ 255.3 million in 2023 and is anticipated to reach US$ 454.2 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
Global core β-nicotinamide mononucleotide (NMN) manufacturers include GeneHarbor, Herbalmax and Genex Formulas etc. The top 3 companies hold a share about 74%.Asia-Pacific is the largest market, with a share about 70%, followed by Americas with the share about 25%.
This report aims to provide a comprehensive presentation of the global market for β-Nicotinamide Mononucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding β-Nicotinamide Mononucleotide.
Report Scope
The β-Nicotinamide Mononucleotide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global β-Nicotinamide Mononucleotide market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the β-Nicotinamide Mononucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Quicksilver Scientific
Age Science
Herbalmax
Genex Formulas
Nutravita
Shinkowa Pharmaceutical
Oriental Yeast
Maac10 Formulas
EffePharm
Nutriop
Bontac
CELFULL
ChromaDex
Kingdomway
Segment by Purity
Above 98%
＜98%
Segment by Application
Drug
Health Products
Cosmetic
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Purity, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of β-Nicotinamide Mononucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of β-Nicotinamide Mononucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of β-Nicotinamide Mononucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Beta-Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide.
The global β-Nicotinamide Mononucleotide market was valued at US$ 255.3 million in 2023 and is anticipated to reach US$ 454.2 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
Global core β-nicotinamide mononucleotide (NMN) manufacturers include GeneHarbor, Herbalmax and Genex Formulas etc. The top 3 companies hold a share about 74%.Asia-Pacific is the largest market, with a share about 70%, followed by Americas with the share about 25%.
This report aims to provide a comprehensive presentation of the global market for β-Nicotinamide Mononucleotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding β-Nicotinamide Mononucleotide.
Report Scope
The β-Nicotinamide Mononucleotide market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global β-Nicotinamide Mononucleotide market comprehensively. Regional market sizes, concerning products by Purity, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the β-Nicotinamide Mononucleotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Purity, by Application, and by regions.
Market Segmentation
By Company
GeneHarbor
Quicksilver Scientific
Age Science
Herbalmax
Genex Formulas
Nutravita
Shinkowa Pharmaceutical
Oriental Yeast
Maac10 Formulas
EffePharm
Nutriop
Bontac
CELFULL
ChromaDex
Kingdomway
Segment by Purity
Above 98%
＜98%
Segment by Application
Drug
Health Products
Cosmetic
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Purity, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of β-Nicotinamide Mononucleotide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of β-Nicotinamide Mononucleotide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of β-Nicotinamide Mononucleotide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 β-Nicotinamide Mononucleotide Market Overview
1.1 Product Definition
1.2 β-Nicotinamide Mononucleotide Segment by Purity
1.2.1 Global β-Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Purity 2023 VS 2030
1.2.2 Above 98%
1.2.3 ＜98%
1.3 β-Nicotinamide Mononucleotide Segment by Application
1.3.1 Global β-Nicotinamide Mononucleotide Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Drug
1.3.3 Health Products
1.3.4 Cosmetic
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global β-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global β-Nicotinamide Mononucleotide Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global β-Nicotinamide Mononucleotide Production Estimates and Forecasts (2019-2030)
1.4.4 Global β-Nicotinamide Mononucleotide Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global β-Nicotinamide Mononucleotide Production Market Share by Manufacturers (2019-2024)
2.2 Global β-Nicotinamide Mononucleotide Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of β-Nicotinamide Mononucleotide, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global β-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global β-Nicotinamide Mononucleotide Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of β-Nicotinamide Mononucleotide, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of β-Nicotinamide Mononucleotide, Product Offered and Application
2.8 Global Key Manufacturers of β-Nicotinamide Mononucleotide, Date of Enter into This Industry
2.9 β-Nicotinamide Mononucleotide Market Competitive Situation and Trends
2.9.1 β-Nicotinamide Mononucleotide Market Concentration Rate
2.9.2 Global 5 and 10 Largest β-Nicotinamide Mononucleotide Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 β-Nicotinamide Mononucleotide Production by Region
3.1 Global β-Nicotinamide Mononucleotide Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global β-Nicotinamide Mononucleotide Production Value by Region (2019-2030)
3.2.1 Global β-Nicotinamide Mononucleotide Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of β-Nicotinamide Mononucleotide by Region (2025-2030)
3.3 Global β-Nicotinamide Mononucleotide Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global β-Nicotinamide Mononucleotide Production by Region (2019-2030)
3.4.1 Global β-Nicotinamide Mononucleotide Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of β-Nicotinamide Mononucleotide by Region (2025-2030)
3.5 Global β-Nicotinamide Mononucleotide Market Price Analysis by Region (2019-2024)
3.6 Global β-Nicotinamide Mononucleotide Production and Value, Year-over-Year Growth
3.6.1 North America β-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe β-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.3 China β-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan β-Nicotinamide Mononucleotide Production Value Estimates and Forecasts (2019-2030)
4 β-Nicotinamide Mononucleotide Consumption by Region
4.1 Global β-Nicotinamide Mononucleotide Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global β-Nicotinamide Mononucleotide Consumption by Region (2019-2030)
4.2.1 Global β-Nicotinamide Mononucleotide Consumption by Region (2019-2024)
4.2.2 Global β-Nicotinamide Mononucleotide Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America β-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America β-Nicotinamide Mononucleotide Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe β-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe β-Nicotinamide Mononucleotide Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific β-Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific β-Nicotinamide Mononucleotide Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa β-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa β-Nicotinamide Mononucleotide Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Purity
5.1 Global β-Nicotinamide Mononucleotide Production by Purity (2019-2030)
5.1.1 Global β-Nicotinamide Mononucleotide Production by Purity (2019-2024)
5.1.2 Global β-Nicotinamide Mononucleotide Production by Purity (2025-2030)
5.1.3 Global β-Nicotinamide Mononucleotide Production Market Share by Purity (2019-2030)
5.2 Global β-Nicotinamide Mononucleotide Production Value by Purity (2019-2030)
5.2.1 Global β-Nicotinamide Mononucleotide Production Value by Purity (2019-2024)
5.2.2 Global β-Nicotinamide Mononucleotide Production Value by Purity (2025-2030)
5.2.3 Global β-Nicotinamide Mononucleotide Production Value Market Share by Purity (2019-2030)
5.3 Global β-Nicotinamide Mononucleotide Price by Purity (2019-2030)
6 Segment by Application
6.1 Global β-Nicotinamide Mononucleotide Production by Application (2019-2030)
6.1.1 Global β-Nicotinamide Mononucleotide Production by Application (2019-2024)
6.1.2 Global β-Nicotinamide Mononucleotide Production by Application (2025-2030)
6.1.3 Global β-Nicotinamide Mononucleotide Production Market Share by Application (2019-2030)
6.2 Global β-Nicotinamide Mononucleotide Production Value by Application (2019-2030)
6.2.1 Global β-Nicotinamide Mononucleotide Production Value by Application (2019-2024)
6.2.2 Global β-Nicotinamide Mononucleotide Production Value by Application (2025-2030)
6.2.3 Global β-Nicotinamide Mononucleotide Production Value Market Share by Application (2019-2030)
6.3 Global β-Nicotinamide Mononucleotide Price by Application (2019-2030)
7 Key Companies Profiled
7.1 GeneHarbor
7.1.1 GeneHarbor β-Nicotinamide Mononucleotide Corporation Information
7.1.2 GeneHarbor β-Nicotinamide Mononucleotide Product Portfolio
7.1.3 GeneHarbor β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.1.4 GeneHarbor Main Business and Markets Served
7.1.5 GeneHarbor Recent Developments/Updates
7.2 Quicksilver Scientific
7.2.1 Quicksilver Scientific β-Nicotinamide Mononucleotide Corporation Information
7.2.2 Quicksilver Scientific β-Nicotinamide Mononucleotide Product Portfolio
7.2.3 Quicksilver Scientific β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Quicksilver Scientific Main Business and Markets Served
7.2.5 Quicksilver Scientific Recent Developments/Updates
7.3 Age Science
7.3.1 Age Science β-Nicotinamide Mononucleotide Corporation Information
7.3.2 Age Science β-Nicotinamide Mononucleotide Product Portfolio
7.3.3 Age Science β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Age Science Main Business and Markets Served
7.3.5 Age Science Recent Developments/Updates
7.4 Herbalmax
7.4.1 Herbalmax β-Nicotinamide Mononucleotide Corporation Information
7.4.2 Herbalmax β-Nicotinamide Mononucleotide Product Portfolio
7.4.3 Herbalmax β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Herbalmax Main Business and Markets Served
7.4.5 Herbalmax Recent Developments/Updates
7.5 Genex Formulas
7.5.1 Genex Formulas β-Nicotinamide Mononucleotide Corporation Information
7.5.2 Genex Formulas β-Nicotinamide Mononucleotide Product Portfolio
7.5.3 Genex Formulas β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Genex Formulas Main Business and Markets Served
7.5.5 Genex Formulas Recent Developments/Updates
7.6 Nutravita
7.6.1 Nutravita β-Nicotinamide Mononucleotide Corporation Information
7.6.2 Nutravita β-Nicotinamide Mononucleotide Product Portfolio
7.6.3 Nutravita β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Nutravita Main Business and Markets Served
7.6.5 Nutravita Recent Developments/Updates
7.7 Shinkowa Pharmaceutical
7.7.1 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Corporation Information
7.7.2 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Product Portfolio
7.7.3 Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Shinkowa Pharmaceutical Main Business and Markets Served
7.7.5 Shinkowa Pharmaceutical Recent Developments/Updates
7.8 Oriental Yeast
7.8.1 Oriental Yeast β-Nicotinamide Mononucleotide Corporation Information
7.8.2 Oriental Yeast β-Nicotinamide Mononucleotide Product Portfolio
7.8.3 Oriental Yeast β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Oriental Yeast Main Business and Markets Served
7.7.5 Oriental Yeast Recent Developments/Updates
7.9 Maac10 Formulas
7.9.1 Maac10 Formulas β-Nicotinamide Mononucleotide Corporation Information
7.9.2 Maac10 Formulas β-Nicotinamide Mononucleotide Product Portfolio
7.9.3 Maac10 Formulas β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Maac10 Formulas Main Business and Markets Served
7.9.5 Maac10 Formulas Recent Developments/Updates
7.10 EffePharm
7.10.1 EffePharm β-Nicotinamide Mononucleotide Corporation Information
7.10.2 EffePharm β-Nicotinamide Mononucleotide Product Portfolio
7.10.3 EffePharm β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.10.4 EffePharm Main Business and Markets Served
7.10.5 EffePharm Recent Developments/Updates
7.11 Nutriop
7.11.1 Nutriop β-Nicotinamide Mononucleotide Corporation Information
7.11.2 Nutriop β-Nicotinamide Mononucleotide Product Portfolio
7.11.3 Nutriop β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Nutriop Main Business and Markets Served
7.11.5 Nutriop Recent Developments/Updates
7.12 Bontac
7.12.1 Bontac β-Nicotinamide Mononucleotide Corporation Information
7.12.2 Bontac β-Nicotinamide Mononucleotide Product Portfolio
7.12.3 Bontac β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Bontac Main Business and Markets Served
7.12.5 Bontac Recent Developments/Updates
7.13 CELFULL
7.13.1 CELFULL β-Nicotinamide Mononucleotide Corporation Information
7.13.2 CELFULL β-Nicotinamide Mononucleotide Product Portfolio
7.13.3 CELFULL β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.13.4 CELFULL Main Business and Markets Served
7.13.5 CELFULL Recent Developments/Updates
7.14 ChromaDex
7.14.1 ChromaDex β-Nicotinamide Mononucleotide Corporation Information
7.14.2 ChromaDex β-Nicotinamide Mononucleotide Product Portfolio
7.14.3 ChromaDex β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.14.4 ChromaDex Main Business and Markets Served
7.14.5 ChromaDex Recent Developments/Updates
7.15 Kingdomway
7.15.1 Kingdomway β-Nicotinamide Mononucleotide Corporation Information
7.15.2 Kingdomway β-Nicotinamide Mononucleotide Product Portfolio
7.15.3 Kingdomway β-Nicotinamide Mononucleotide Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Kingdomway Main Business and Markets Served
7.15.5 Kingdomway Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 β-Nicotinamide Mononucleotide Industry Chain Analysis
8.2 β-Nicotinamide Mononucleotide Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 β-Nicotinamide Mononucleotide Production Mode & Process
8.4 β-Nicotinamide Mononucleotide Sales and Marketing
8.4.1 β-Nicotinamide Mononucleotide Sales Channels
8.4.2 β-Nicotinamide Mononucleotide Distributors
8.5 β-Nicotinamide Mononucleotide Customers
9 β-Nicotinamide Mononucleotide Market Dynamics
9.1 β-Nicotinamide Mononucleotide Industry Trends
9.2 β-Nicotinamide Mononucleotide Market Drivers
9.3 β-Nicotinamide Mononucleotide Market Challenges
9.4 β-Nicotinamide Mononucleotide Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global β-Nicotinamide Mononucleotide Market Value by Purity, (US$ Million) & (2023 VS 2030)
Table 2. Global β-Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2023 VS 2030)
Table 3. Global β-Nicotinamide Mononucleotide Production Capacity (Tons) by Manufacturers in 2023
Table 4. Global β-Nicotinamide Mononucleotide Production by Manufacturers (2019-2024) & (Tons)
Table 5. Global β-Nicotinamide Mononucleotide Production Market Share by Manufacturers (2019-2024)
Table 6. Global β-Nicotinamide Mononucleotide Production Value by Manufacturers (2019-2024) & (US$ Million)
Table 7. Global β-Nicotinamide Mononucleotide Production Value Share by Manufacturers (2019-2024)
Table 8. Global β-Nicotinamide Mononucleotide Industry Ranking 2022 VS 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in β-Nicotinamide Mononucleotide as of 2023)
Table 10. Global Market β-Nicotinamide Mononucleotide Average Price by Manufacturers (US$/Ton) & (2019-2024)
Table 11. Manufacturers β-Nicotinamide Mononucleotide Production Sites and Area Served
Table 12. Manufacturers β-Nicotinamide Mononucleotide Product Types
Table 13. Global β-Nicotinamide Mononucleotide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion
Table 15. Global β-Nicotinamide Mononucleotide Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 16. Global β-Nicotinamide Mononucleotide Production Value (US$ Million) by Region (2019-2024)
Table 17. Global β-Nicotinamide Mononucleotide Production Value Market Share by Region (2019-2024)
Table 18. Global β-Nicotinamide Mononucleotide Production Value (US$ Million) Forecast by Region (2025-2030)
Table 19. Global β-Nicotinamide Mononucleotide Production Value Market Share Forecast by Region (2025-2030)
Table 20. Global β-Nicotinamide Mononucleotide Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Table 21. Global β-Nicotinamide Mononucleotide Production (Tons) by Region (2019-2024)
Table 22. Global β-Nicotinamide Mononucleotide Production Market Share by Region (2019-2024)
Table 23. Global β-Nicotinamide Mononucleotide Production (Tons) Forecast by Region (2025-2030)
Table 24. Global β-Nicotinamide Mononucleotide Production Market Share Forecast by Region (2025-2030)
Table 25. Global β-Nicotinamide Mononucleotide Market Average Price (US$/Ton) by Region (2019-2024)
Table 26. Global β-Nicotinamide Mononucleotide Market Average Price (US$/Ton) by Region (2025-2030)
Table 27. Global β-Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 28. Global β-Nicotinamide Mononucleotide Consumption by Region (2019-2024) & (Tons)
Table 29. Global β-Nicotinamide Mononucleotide Consumption Market Share by Region (2019-2024)
Table 30. Global β-Nicotinamide Mononucleotide Forecasted Consumption by Region (2025-2030) & (Tons)
Table 31. Global β-Nicotinamide Mononucleotide Forecasted Consumption Market Share by Region (2019-2024)
Table 32. North America β-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 33. North America β-Nicotinamide Mononucleotide Consumption by Country (2019-2024) & (Tons)
Table 34. North America β-Nicotinamide Mononucleotide Consumption by Country (2025-2030) & (Tons)
Table 35. Europe β-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 36. Europe β-Nicotinamide Mononucleotide Consumption by Country (2019-2024) & (Tons)
Table 37. Europe β-Nicotinamide Mononucleotide Consumption by Country (2025-2030) & (Tons)
Table 38. Asia Pacific β-Nicotinamide Mononucleotide Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Tons)
Table 39. Asia Pacific β-Nicotinamide Mononucleotide Consumption by Region (2019-2024) & (Tons)
Table 40. Asia Pacific β-Nicotinamide Mononucleotide Consumption by Region (2025-2030) & (Tons)
Table 41. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Tons)
Table 42. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide Consumption by Country (2019-2024) & (Tons)
Table 43. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide Consumption by Country (2025-2030) & (Tons)
Table 44. Global β-Nicotinamide Mononucleotide Production (Tons) by Purity (2019-2024)
Table 45. Global β-Nicotinamide Mononucleotide Production (Tons) by Purity (2025-2030)
Table 46. Global β-Nicotinamide Mononucleotide Production Market Share by Purity (2019-2024)
Table 47. Global β-Nicotinamide Mononucleotide Production Market Share by Purity (2025-2030)
Table 48. Global β-Nicotinamide Mononucleotide Production Value (US$ Million) by Purity (2019-2024)
Table 49. Global β-Nicotinamide Mononucleotide Production Value (US$ Million) by Purity (2025-2030)
Table 50. Global β-Nicotinamide Mononucleotide Production Value Share by Purity (2019-2024)
Table 51. Global β-Nicotinamide Mononucleotide Production Value Share by Purity (2025-2030)
Table 52. Global β-Nicotinamide Mononucleotide Price (US$/Ton) by Purity (2019-2024)
Table 53. Global β-Nicotinamide Mononucleotide Price (US$/Ton) by Purity (2025-2030)
Table 54. Global β-Nicotinamide Mononucleotide Production (Tons) by Application (2019-2024)
Table 55. Global β-Nicotinamide Mononucleotide Production (Tons) by Application (2025-2030)
Table 56. Global β-Nicotinamide Mononucleotide Production Market Share by Application (2019-2024)
Table 57. Global β-Nicotinamide Mononucleotide Production Market Share by Application (2025-2030)
Table 58. Global β-Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2019-2024)
Table 59. Global β-Nicotinamide Mononucleotide Production Value (US$ Million) by Application (2025-2030)
Table 60. Global β-Nicotinamide Mononucleotide Production Value Share by Application (2019-2024)
Table 61. Global β-Nicotinamide Mononucleotide Production Value Share by Application (2025-2030)
Table 62. Global β-Nicotinamide Mononucleotide Price (US$/Ton) by Application (2019-2024)
Table 63. Global β-Nicotinamide Mononucleotide Price (US$/Ton) by Application (2025-2030)
Table 64. GeneHarbor β-Nicotinamide Mononucleotide Corporation Information
Table 65. GeneHarbor Specification and Application
Table 66. GeneHarbor β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 67. GeneHarbor Main Business and Markets Served
Table 68. GeneHarbor Recent Developments/Updates
Table 69. Quicksilver Scientific β-Nicotinamide Mononucleotide Corporation Information
Table 70. Quicksilver Scientific Specification and Application
Table 71. Quicksilver Scientific β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 72. Quicksilver Scientific Main Business and Markets Served
Table 73. Quicksilver Scientific Recent Developments/Updates
Table 74. Age Science β-Nicotinamide Mononucleotide Corporation Information
Table 75. Age Science Specification and Application
Table 76. Age Science β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 77. Age Science Main Business and Markets Served
Table 78. Age Science Recent Developments/Updates
Table 79. Herbalmax β-Nicotinamide Mononucleotide Corporation Information
Table 80. Herbalmax Specification and Application
Table 81. Herbalmax β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 82. Herbalmax Main Business and Markets Served
Table 83. Herbalmax Recent Developments/Updates
Table 84. Genex Formulas β-Nicotinamide Mononucleotide Corporation Information
Table 85. Genex Formulas Specification and Application
Table 86. Genex Formulas β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 87. Genex Formulas Main Business and Markets Served
Table 88. Genex Formulas Recent Developments/Updates
Table 89. Nutravita β-Nicotinamide Mononucleotide Corporation Information
Table 90. Nutravita Specification and Application
Table 91. Nutravita β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 92. Nutravita Main Business and Markets Served
Table 93. Nutravita Recent Developments/Updates
Table 94. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Corporation Information
Table 95. Shinkowa Pharmaceutical Specification and Application
Table 96. Shinkowa Pharmaceutical β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 97. Shinkowa Pharmaceutical Main Business and Markets Served
Table 98. Shinkowa Pharmaceutical Recent Developments/Updates
Table 99. Oriental Yeast β-Nicotinamide Mononucleotide Corporation Information
Table 100. Oriental Yeast Specification and Application
Table 101. Oriental Yeast β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 102. Oriental Yeast Main Business and Markets Served
Table 103. Oriental Yeast Recent Developments/Updates
Table 104. Maac10 Formulas β-Nicotinamide Mononucleotide Corporation Information
Table 105. Maac10 Formulas Specification and Application
Table 106. Maac10 Formulas β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 107. Maac10 Formulas Main Business and Markets Served
Table 108. Maac10 Formulas Recent Developments/Updates
Table 109. EffePharm β-Nicotinamide Mononucleotide Corporation Information
Table 110. EffePharm Specification and Application
Table 111. EffePharm β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 112. EffePharm Main Business and Markets Served
Table 113. EffePharm Recent Developments/Updates
Table 114. Nutriop β-Nicotinamide Mononucleotide Corporation Information
Table 115. Nutriop Specification and Application
Table 116. Nutriop β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 117. Nutriop Main Business and Markets Served
Table 118. Nutriop Recent Developments/Updates
Table 119. Bontac β-Nicotinamide Mononucleotide Corporation Information
Table 120. Bontac Specification and Application
Table 121. Bontac β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 122. Bontac Main Business and Markets Served
Table 123. Bontac Recent Developments/Updates
Table 124. CELFULL β-Nicotinamide Mononucleotide Corporation Information
Table 125. CELFULL Specification and Application
Table 126. CELFULL β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 127. CELFULL Main Business and Markets Served
Table 128. CELFULL Recent Developments/Updates
Table 129. ChromaDex β-Nicotinamide Mononucleotide Corporation Information
Table 130. ChromaDex Specification and Application
Table 131. ChromaDex β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 132. ChromaDex Main Business and Markets Served
Table 133. ChromaDex Recent Developments/Updates
Table 134. ChromaDex β-Nicotinamide Mononucleotide Corporation Information
Table 135. Kingdomway Specification and Application
Table 136. Kingdomway β-Nicotinamide Mononucleotide Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 137. Kingdomway Main Business and Markets Served
Table 138. Kingdomway Recent Developments/Updates
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. β-Nicotinamide Mononucleotide Distributors List
Table 142. β-Nicotinamide Mononucleotide Customers List
Table 143. β-Nicotinamide Mononucleotide Market Trends
Table 144. β-Nicotinamide Mononucleotide Market Drivers
Table 145. β-Nicotinamide Mononucleotide Market Challenges
Table 146. β-Nicotinamide Mononucleotide Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of β-Nicotinamide Mononucleotide
Figure 2. Global β-Nicotinamide Mononucleotide Market Value by Purity, (US$ Million) & (2023 VS 2030)
Figure 3. Global β-Nicotinamide Mononucleotide Market Share by Purity: 2023 VS 2030
Figure 4. Above 98% Product Picture
Figure 5. ＜98% Product Picture
Figure 6. Global β-Nicotinamide Mononucleotide Market Value by Application, (US$ Million) & (2023 VS 2030)
Figure 7. Global β-Nicotinamide Mononucleotide Market Share by Application: 2023 VS 2030
Figure 8. Drug
Figure 9. Health Products
Figure 10. Cosmetic
Figure 11. Others
Figure 12. Global β-Nicotinamide Mononucleotide Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global β-Nicotinamide Mononucleotide Production Value (US$ Million) & (2019-2030)
Figure 14. Global β-Nicotinamide Mononucleotide Production Capacity (Tons) & (2019-2030)
Figure 15. Global β-Nicotinamide Mononucleotide Production (Tons) & (2019-2030)
Figure 16. Global β-Nicotinamide Mononucleotide Average Price (US$/Ton) & (2019-2030)
Figure 17. β-Nicotinamide Mononucleotide Report Years Considered
Figure 18. β-Nicotinamide Mononucleotide Production Share by Manufacturers in 2023
Figure 19. β-Nicotinamide Mononucleotide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 20. The Global 5 and 10 Largest Players: Market Share by β-Nicotinamide Mononucleotide Revenue in 2023
Figure 21. Global β-Nicotinamide Mononucleotide Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global β-Nicotinamide Mononucleotide Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. Global β-Nicotinamide Mononucleotide Production Comparison by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 24. Global β-Nicotinamide Mononucleotide Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 25. North America β-Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Europe β-Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. China β-Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 28. Japan β-Nicotinamide Mononucleotide Production Value (US$ Million) Growth Rate (2019-2030)
Figure 29. Global β-Nicotinamide Mononucleotide Consumption by Region: 2019 VS 2023 VS 2030 (Tons)
Figure 30. Global β-Nicotinamide Mononucleotide Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 31. North America β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 32. North America β-Nicotinamide Mononucleotide Consumption Market Share by Country (2019-2030)
Figure 33. Canada β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 34. U.S. β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 35. Europe β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 36. Europe β-Nicotinamide Mononucleotide Consumption Market Share by Country (2019-2030)
Figure 37. Germany β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 38. France β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 39. U.K. β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 40. Italy β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 41. Russia β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 42. Asia Pacific β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 43. Asia Pacific β-Nicotinamide Mononucleotide Consumption Market Share by Regions (2019-2030)
Figure 44. China β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 45. Japan β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 46. South Korea β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 47. China Taiwan β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 48. Southeast Asia β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 49. India β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 50. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 51. Latin America, Middle East & Africa β-Nicotinamide Mononucleotide Consumption Market Share by Country (2019-2030)
Figure 52. Mexico β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 53. Brazil β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 54. Turkey β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 55. GCC Countries β-Nicotinamide Mononucleotide Consumption and Growth Rate (2019-2024) & (Tons)
Figure 56. Global Production Market Share of β-Nicotinamide Mononucleotide by Purity (2019-2030)
Figure 57. Global Production Value Market Share of β-Nicotinamide Mononucleotide by Purity (2019-2030)
Figure 58. Global β-Nicotinamide Mononucleotide Price (US$/Ton) by Purity (2019-2030)
Figure 59. Global Production Market Share of β-Nicotinamide Mononucleotide by Application (2019-2030)
Figure 60. Global Production Value Market Share of β-Nicotinamide Mononucleotide by Application (2019-2030)
Figure 61. Global β-Nicotinamide Mononucleotide Price (US$/Ton) by Application (2019-2030)
Figure 62. β-Nicotinamide Mononucleotide Value Chain
Figure 63. β-Nicotinamide Mononucleotide Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
